Menopause Largely Missing from Electronic Health Records Despite Its Health Impact
study of nearly 240,000 women finds only 12% of electronic records include menopause status, even though over half reported being in transition.

Menopause is a natural midlife transition that significantly influences future risks for heart disease, osteoporosis and other conditions, yet it remains inconsistently documented in electronic health records (EHRs). Researchers analyzing EHRs from almost 240,000 women in the NIH’s All of Us Research Program found that just 12% of records included any mention of menopause, despite more than half of participants reporting they were experiencing the transition.
The study, published in Menopause, revealed gaps not only in whether menopause was recorded, but also in details like age at onset and symptom presence, such as hot flashes or sleep disturbances. Discrepancies existed between patient self-reports and EHR entries, with variations by age, education, race and income. Researchers noted that menopause is often overlooked in clinical practice, possibly because it is not a disease and clinicians may not see it as requiring a diagnostic code.
To address this data gap, the team is piloting a brief patient-completed questionnaire integrated into clinic check-ins, developing algorithms to infer menopause status from existing data, and exploring how social and systemic factors influence documentation practices.
First reported by Medical Xpress.
Prepared with AI assistance from the cited sources.
The Cali Reporter newsletter
The stories worth your time.
California, the country, and what comes next. Join our free newsletter for reporting that keeps you informed.
More in Health & Medicine
- Brain Energy Mismatches in Schizophrenia
A new study explores the potential role of energy bottlenecks in brain cells in explaining fragmented experiences of time, space, and self in schizophrenia.
- Brazil Reports First Mpox Death in 2026
Brazil has recorded its first mpox-related death in 2026, but public health officials are not classifying the current surge in cases as an outbreak, according to the Fiocruz Institute.
- Personalized Therapies for IBD May Target Specific Harmful Gut Bacteria
A study led by Dr. Lukas Mager and Prof. Kathy McCoy has identified two gut bacteria that promote inflammation in inflammatory bowel disease, opening the door for personalized treatments.
